In 2025, the landscape of treating Severe Acute Malnutrition (SAM) and Moderate Acute Malnutrition (MAM) is being transformed by simplified, unified protocols, a major step forward for children, families, and frontline health workers worldwide.
As a leading manufacturer of RUTF, RUSF, and LNS as well as a trusted partner to world organisations on a mission to fight malnutrition, Nuflower is proud to be at the forefront of these innovations that can change the lives of children and give them a better shot at a healthier life.
Why Do We Need Simplified Protocols?
Traditional approaches to SAM and MAM rely on a number of criteria, separate products and treatment sites. When so many variables are involved, complexity and chaos ensue. Some of the major concerns are delays in care, logistical bottlenecks and lower coverage rates.
Some recent studies, as well as field experience, show that simpler, unified protocols can drastically improve recovery rates and program efficiency.
What’s New in 2025?
-
- Community-Based Care
We have covered the benefits of community-based care earlier, and it is shown that it increases coverage and reduces default rates. The treatment for malnutrition is increasingly decentralised, but with community health workers delivering care and follow-up to ensure better coverage and default rates, making treatment accessible even in remote areas or in the case of emergencies.
- Community-Based Care
-
- Proven Effectiveness of RUTF & RUSF
A few new studies have indicated that simpler protocols achieve better recovery rates, sometimes beyond the usual, meeting or exceeding humanitarian standards. This, in effect, means reduced costs per child treated, making programs more sustainable.
- Proven Effectiveness of RUTF & RUSF
The Impact: Real-World Results
Implementing a simplified protocol for the treatment of MAM based on MUAC as the sole criterion for admission and discharge, a fixed daily dose of one RUTF and involving Community Health Workers as treatment providers could significantly improve the effectiveness and coverage of treatment programmes compared to standard protocols.
By treating SAM and MAM as a continuum of acute malnutrition, children receive care earlier, and the risk of deterioration is minimised. The need for two separate food products is eliminated, simplifying supply chains and training.
Looking Ahead
As a manufacturer committed to quality and innovation, we are scaling up production of RUTF and working closely with our partners to ensure a reliable supply chain, even in the most challenging contexts. We are also investing in research to further optimize dosages and protocols for different regions and populations.
Our goal for 2025 and beyond:
Ensure every child with acute malnutrition, whether SAM or MAM, has access to simple, effective, and timely treatment.
Support the global shift toward unified, evidence-based care for malnutrition.
Together, we can make malnutrition history – one simplified protocol at a time. For more information on our work and products, or to partner with us in the fight against malnutrition, contact Nuflower today.